RapidAI
RapidAI is a neuroimaging company that focuses on enhancing diagnostic and treatment decisions for stroke and aneurysm patients. Its platform leverages artificial intelligence to generate advanced images from non-contrast CT, CT Angiography, CT perfusion, and MRI diffusion and perfusion scans. By providing advanced viewing, processing, and analysis capabilities for brain images, RapidAI supports clinicians in making more accurate assessments, ultimately improving patient outcomes in critical situations involving strokes and related conditions.
1 past transactions
EndoVantage
Acquisition in 2020
EndoVantage develops a cloud-based platform that uses real patient data to plan personalized endovascular treatments. It offers tools for clinicians to calculate aneurysmal volume, select optimal treatment strategies, and review outcomes before surgery. The company also provides services for medical device companies, including device comparisons and training.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.